Related Experiment Video
Updated: Jul 4, 2026
09:52
Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
11.0K
Diagnostic approach for post-COVID-19 mucormycosis
Ankita Mathur1, Vishnu T Obulareddy2, Praveen K Kamma3
1Department of Dental Research Cell, Dr. D.Y. Patil Dental College and Hospital, Dr. D.Y. Patil Vidyapeeth, Pune, India.
Minerva Dental and Oral Science
|September 9, 2025
Summary
The COVID-19 pandemic has increased mucormycosis fungal infections in India, especially in diabetic patients. This study explores the link between COVID-19 and mucormycosis to understand this dangerous opportunistic infection.
Area of Science:
- Infectious Diseases
- Mycology
- Public Health
Background:
- The COVID-19 pandemic, particularly in India, remains a significant public health concern.
- The second wave of COVID-19 has seen a rise in opportunistic infections, including mucormycosis, a fungal infection.
- Mucormycosis is increasingly prevalent in COVID-19 patients, especially those with comorbidities like diabetes, and can cause secondary infections.
Purpose of the Study:
- To investigate the correlation between mucormycosis and COVID-19 patients.
- To elucidate the molecular mechanisms of mucormycosis.
- To enhance understanding of fungal infections in SARS-CoV-2 patients.
Main Methods:
- Observational study design.
- Correlation analysis between COVID-19 infection and mucormycosis incidence.
- Molecular mechanism investigation of fungal pathogens.
Main Results:
- Significant increase in mucormycosis cases among COVID-19 patients observed.
- Comorbidities, particularly diabetes, identified as major risk factors.
- Preliminary molecular insights into host-pathogen interactions provided.
Conclusions:
- COVID-19 poses a significant risk for developing mucormycosis, especially in immunocompromised individuals with diabetes.
- Further research into the molecular mechanisms of mucormycosis is crucial for developing targeted treatments.
- Public health strategies are needed to manage opportunistic infections during pandemics.
Related Concept Videos
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:26Sputum Studies I: Gram Stain, cytology, and Acid-fast smear and culture
Sputum studies are a critical part of diagnosing and treating numerous respiratory conditions. These studies involve obtaining sputum samples for analysis to identify pathogenic organisms and assess the presence of abnormal cells indicative of malignant conditions. This lesson will delve into three fundamental sputum studies: Gram Stain, Cytology, and Acid-fast Smear and Culture.
Gram Stain
The Gram Stain is an integral part of sputum studies. It involves the staining of sputum, which permits...
Gram Stain
The Gram Stain is an integral part of sputum studies. It involves the staining of sputum, which permits...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...